MoneyWorks4Me

Morepen Laboratories - Quaterly Results

12 Aug 2024 Evaluate
The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 3856.43 millions.The company almost doubled its revenue to Rs. 350.50 millions  from Rs. 158.49 millions in the quarter ended June 2024.OP of the company witnessed a marginal growth to 516.82 millions from 268.87 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3856.43 3691.03 4.48 3856.43 3691.03 4.48 15375.94 13388.83 14.84
Other Income 30.72 20.84 47.41 30.72 20.84 47.41 125.66 57.59 118.20
PBIDT 516.82 268.87 92.22 516.82 268.87 92.22 1743.84 830.29 110.03
Interest 10.44 2.83 268.90 10.44 2.83 268.90 35.09 19.81 77.13
PBDT 506.38 266.04 90.34 506.38 266.04 90.34 1708.75 810.48 110.83
Depreciation 35.90 48.93 -26.63 35.90 48.93 -26.63 219.00 180.06 21.63
PBT 470.48 217.11 116.70 470.48 217.11 116.70 1489.75 630.42 136.31
TAX 119.98 58.62 104.67 119.98 58.62 104.67 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 350.50 158.49 121.15 350.50 158.49 121.15 1109.35 462.43 139.90
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 1022.27 0.00
PBIDTM(%) 13.40 7.28 83.98 13.40 7.28 83.98 11.34 6.20 82.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..